Piflufolastat
Ended Awarded Last action
- Contract number
- 36C26023F0366
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,435
Award facts
- Contract value 100% obligated
- $14,434.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$400,568 | |
| Original award | $415,003 |
About this award
This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc., a prominent for-profit corporation specializing in the development, manufacturing, and distribution of diagnostic medical imaging agents and radiopharmaceuticals.
The contract, with a ceiling value of $14,434.88, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is not set aside for small businesses. Progenics Pharmaceuticals holds several significant federal contract Indefinite Delivery Vehicles (IDVs), including multiple Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency, with values ranging from $250,000 to $6.5 million. These IDVs primarily cover the procurement of radiopharmaceuticals, such as PYLARIFY, for use in prostate cancer imaging across various VA and military medical facilities.
Quick answers
Who was awarded contract 36C26023F0366?
36C26023F0366 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 14, 2023.
How much is contract 36C26023F0366 worth?
The government has obligated $14,435 on 36C26023F0366.
Is contract 36C26023F0366 an order under another contract?
Yes. 36C26023F0366 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26023F0366 competed?
The extent of competition for 36C26023F0366 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award